Success Metrics

Clinical Success Rate
100.0%

Based on 22 completed trials

Completion Rate
100%(22/22)
Active Trials
5(16%)
Results Posted
32%(7 trials)

Phase Distribution

Ph not_applicable
7
22%
Ph phase_1
1
3%
Ph phase_2
4
13%
Ph phase_3
9
28%
Ph phase_4
6
19%
Ph early_phase_1
1
3%

Phase Distribution

2

Early Stage

4

Mid Stage

15

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
1(3.6%)
Phase 2Efficacy & side effects
4(14.3%)
Phase 3Large-scale testing
9(32.1%)
Phase 4Post-market surveillance
6(21.4%)
N/ANon-phased studies
7(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

22 of 24 finished

Non-Completion Rate

8.3%

2 ended early

Currently Active

5

trials recruiting

Total Trials

32

all time

Status Distribution
Active(5)
Completed(22)
Terminated(2)
Other(3)

Detailed Status

Completed22
unknown3
Recruiting3
Active, not recruiting2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
32
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 11 (3.6%)
Phase 24 (14.3%)
Phase 39 (32.1%)
Phase 46 (21.4%)
N/A7 (25.0%)

Trials by Status

active_not_recruiting26%
unknown39%
withdrawn26%
recruiting39%
completed2269%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05100017Not Applicable

Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure

Active Not Recruiting
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT02483793Not Applicable

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Withdrawn
NCT03919955Phase 2

A Novel Pharmacological Therapy for Obstructive Sleep Apnea

Completed
NCT01855256Phase 3

Treatment of Hyperhidrosis With Oxybutynin

Completed
NCT07030803Not Applicable

Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation

Recruiting
NCT06106529Phase 3

REDucing Hot FLASHes in Women Using Endocrine Therapy.

Recruiting
NCT06737016Phase 3

Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

Recruiting
NCT03602508

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

Completed
NCT01192568Phase 4

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Completed
NCT05550246Phase 1

Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy

Unknown
NCT03877289Phase 4

Efficacy of Oxybutynin in Paediatric Cystitis

Completed
NCT03205605Early Phase 1

Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products

Completed
NCT01557244Phase 3

A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Completed
NCT03572231

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

Completed
NCT02240459Phase 2

A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment

Completed
NCT02973659Not Applicable

The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.

Completed
NCT02099695Phase 3

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis

Withdrawn
NCT02704013Not Applicable

Urinary Biomarkers in Overactive Bladder in Children

Unknown
NCT02538302Phase 3

Minirin Versus Oxybutynin for Nocturnal Enuresis in Children

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32